Sivem Afach

770 total citations
17 papers, 452 citations indexed

About

Sivem Afach is a scholar working on Immunology, Dermatology and Complementary and alternative medicine. According to data from OpenAlex, Sivem Afach has authored 17 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Dermatology and 5 papers in Complementary and alternative medicine. Recurrent topics in Sivem Afach's work include Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (8 papers) and Meta-analysis and systematic reviews (5 papers). Sivem Afach is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (10 papers), Dermatology and Skin Diseases (8 papers) and Meta-analysis and systematic reviews (5 papers). Sivem Afach collaborates with scholars based in France, United Kingdom and Spain. Sivem Afach's co-authors include É. Sbidian, Laurence Le Cleach, Anna Chaimani, Carolyn Hughes, Luigi Naldi, Camille Hua, I. García‐Doval, Liz Doney, Corinna Dressler and Theodoros Evrenoglou and has published in prestigious journals such as Annals of Internal Medicine, Cochrane Database of Systematic Reviews and Journal of Clinical Epidemiology.

In The Last Decade

Sivem Afach

16 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sivem Afach France 9 330 203 75 61 57 17 452
Canelle Mazaud France 5 296 0.9× 173 0.9× 64 0.9× 59 1.0× 40 0.7× 6 390
Achim Guettner Switzerland 8 436 1.3× 325 1.6× 31 0.4× 109 1.8× 17 0.3× 10 558
Tianshuang Wu United States 9 395 1.2× 483 2.4× 54 0.7× 174 2.9× 42 0.7× 21 735
M.I.A. Koetsier Netherlands 12 311 0.9× 176 0.9× 98 1.3× 59 1.0× 80 1.4× 14 408
R. Jiménez‐Puya Spain 12 401 1.2× 232 1.1× 93 1.2× 69 1.1× 59 1.0× 28 567
J. Crowley United States 5 303 0.9× 158 0.8× 26 0.3× 66 1.1× 48 0.8× 6 429
N. Cichanowitz United States 6 479 1.5× 335 1.7× 44 0.6× 146 2.4× 24 0.4× 11 612
C. Horreau France 5 459 1.4× 203 1.0× 50 0.7× 69 1.1× 15 0.3× 6 604
M‐A Richard‐Lallemand France 6 535 1.6× 300 1.5× 130 1.7× 42 0.7× 15 0.3× 7 620
Q. Li United States 6 318 1.0× 221 1.1× 21 0.3× 91 1.5× 13 0.2× 20 367

Countries citing papers authored by Sivem Afach

Since Specialization
Citations

This map shows the geographic impact of Sivem Afach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sivem Afach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sivem Afach more than expected).

Fields of papers citing papers by Sivem Afach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sivem Afach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sivem Afach. The network helps show where Sivem Afach may publish in the future.

Co-authorship network of co-authors of Sivem Afach

This figure shows the co-authorship network connecting the top 25 collaborators of Sivem Afach. A scholar is included among the top collaborators of Sivem Afach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sivem Afach. Sivem Afach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sbidian, É., et al.. (2025). Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews. 2025(8). CD011535–CD011535. 1 indexed citations
3.
Afach, Sivem, Antoine Meyer, Zenas Z N Yiu, et al.. (2024). Funding and conclusions of network meta-analyses on targeted therapies in inflammatory diseases: an overview. Journal of Clinical Epidemiology. 172. 111411–111411. 1 indexed citations
4.
Tran, Viet-Thi, Gerald Gartlehner, Sally Yaacoub, et al.. (2024). Sensitivity and Specificity of Using GPT-3.5 Turbo Models for Title and Abstract Screening in Systematic Reviews and Meta-analyses. Annals of Internal Medicine. 177(6). 791–799. 22 indexed citations
5.
Chaimani, Anna, Rosa Parisi, Laëtitia Penso, et al.. (2024). Serious adverse events associated with systemic treatments for psoriasis: a network meta-analysis of observational studies and randomized controlled trials. Cochrane Database of Systematic Reviews. 2024(4). 1 indexed citations
6.
Cleach, Laurence Le, et al.. (2023). Long-term clinical trials of biologics in plaque psoriasis demonstrate heterogeneous study designs. British Journal of Dermatology. 188(5). 677–678. 2 indexed citations
7.
Sbidian, É., Anna Chaimani, I. García‐Doval, et al.. (2023). Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews. 2023(7). CD011535–CD011535. 58 indexed citations
8.
Evrenoglou, Theodoros, Ian R. White, Sivem Afach, Dimitris Mavridis, & Anna Chaimani. (2022). Network meta‐analysis of rare events using penalized likelihood regression. Statistics in Medicine. 41(26). 5203–5219. 14 indexed citations
9.
Sbidian, É., Anna Chaimani, I. García‐Doval, et al.. (2022). Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews. 2022(8). CD011535–CD011535. 80 indexed citations
10.
Afach, Sivem, Theodoros Evrenoglou, Nadia Oubaya, Laurence Le Cleach, & É. Sbidian. (2021). Most randomized controlled trials for psoriasis used placebo comparators despite the availability of effective treatments. Journal of Clinical Epidemiology. 133. 72–79. 3 indexed citations
11.
Afach, Sivem, Jean-Philippe Régnaux, G. Chaby, et al.. (2021). Overlapping network meta‐analyses on psoriasis systemic treatments, an overview: quantity does not make quality. British Journal of Dermatology. 187(1). 29–41. 11 indexed citations
12.
Sbidian, É., Anna Chaimani, I. García‐Doval, et al.. (2021). Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews. 2021(12). 96 indexed citations
13.
Afach, Sivem, Canelle Mazaud, C. Phan, et al.. (2020). Quality and Reporting Completeness of Systematic Reviews and Meta-Analyses in Dermatology. Journal of Investigative Dermatology. 141(1). 64–71. 8 indexed citations
14.
Afach, Sivem, Anna Chaimani, Theodoros Evrenoglou, et al.. (2020). Meta‐analysis results do not reflect the real safety of biologics in psoriasis*. British Journal of Dermatology. 184(3). 415–424. 23 indexed citations
15.
Sbidian, É., Anna Chaimani, I. García‐Doval, et al.. (2020). Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database of Systematic Reviews. 1. CD011535–CD011535. 128 indexed citations
16.
Afach, Sivem, et al.. (2019). 151. DRUG-RELATED IGA VASCULITIS (HENOCH–SCHöNLEIN): A SYSTEMATIC LITERATURE REVIEW. Lara D. Veeken. 58(Supplement_2).
17.
Afach, Sivem, et al.. (2018). Vascularites à IgA (purpura rhumatoïde, VIgA) d’origine médicamenteuse : revue systématique de la littérature. La Revue de Médecine Interne. 39. A102–A103. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026